Gestational Diabetes Screening and Management: Leveraging evidence from birth cohorts and clinical trials in India and South Africa

Gestational diabetes mellitus (GDM) is a major public health concern, affecting about one out of every six pregnancies. The condition is not only associated with adverse pregnancy outcomes for both the mother and the offspring, but is associated with short-term and long-term cardiometabolic health of both. Although screening and treatment protocols are well established in high-income countries, there are considerable gaps in their global implementation. 

More

Event Details:

February 13, 2026
1:30-3:00pm, MT
Zoom Webinar

Register

Session Chair: Giridhara Rathnaiah Babu, Qatar University, College Of Medicine, QU Health

Presenters

Andrew Williams
Discussant

Naomi Levitt
Integrated health system intervention aimed at reducing type 2 diabetes risk in women after gestational diabetes in South Africa (IINDIAGO): a randomised controlled trial

Tawanda Chivese
Threshold Matters: Revisiting Glycemic Criteria for Gestational Diabetes through RCT Evidence

Giridhara Rathnaiah Babu
Tackling the Silent Burden of Gestational Diabetes: India’s Intergenerational Health Crisis

Event Recording Available to SER Members

Recording Access Details

Thank you for your interest in SER webinars! Please note that the recording will be made available a few days after the event and will be accessible exclusively to SER members.

If you’re not currently a member, we encourage you to Join SER to gain access to this and future recordings, along with other member benefits.

📽️ Once available, the recording will appear below this message.